SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid heated debates surrounding a recent shooting involving Charlie Kirk, with community members expressing strong opinions and assigning blame.  Discussions are centered around political affiliations, violence, and potential motives.  This heightened activity occurs within the context of ongoing scrutiny and differing perspectives on the company and its ties to broader political narratives.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as the company announced volume shipments of its Nvidia Blackwell Ultra solutions, sparking positive sentiment. The community is discussing potential analyst earnings revisions and a complete rerating of the stock due to this catalyst. Bullish investors believe SMCI is undervalued and see substantial upside, while some express caution regarding historical compliance issues.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock experiences a notable intraday surge, sparking discussions about a potential breakout and renewed investor confidence. Community members are actively debating whether this rally has the momentum to reach key resistance levels like $400, while others are wary of a potential pullback. Broader market factors and news around Tesla's autonomous vehicle testing are also contributing to the increased attention.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI (RZLV) is trending due to a recent surge in stock price and discussions around its potential valuation compared to AI peers, with the community highlighting its innovative visual search technology and upcoming earnings report on October 1st as potential catalysts. Community members are actively discussing the possibility of a short squeeze, strategic partnerships, and the potential for significant upward volatility. Speculation is high regarding upcoming announcements and potential catalysts that could further drive the stock's momentum.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as community members discuss a potential short squeeze and buyout, fueled by recent price action. Chatter revolves around the possibility of trapped shorts and speculation regarding potential FDA approval. Community members are discussing the potential for a buyout before the end of the year.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending due to a recently announced non-binding agreement with OpenAI, sparking discussions about its potential impact on both companies and the broader AI landscape; the community is analyzing the news for its implications on Microsoft's AI strategy and its competitive positioning against companies like Google. Some traders anticipate a rotation of investments into MSFT, while others remain skeptical, citing concerns about valuation and historical price action.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe's AI-influenced revenue and recent earnings beat have sparked debate about its growth potential, with the community weighing the impact of AI adoption and future guidance. While some see a path to new highs, others express concerns about competition and past performance after earnings, creating uncertainty. Traders are also actively discussing potential price movements and option strategies around the earnings release.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending following reports that Paramount Skydance is preparing a takeover bid, potentially leading to a bidding war. Community members are speculating on the offer price, potential bidders, and the implications for the streaming landscape, with some expressing bullish sentiment and others cautioning about a possible pullback. Takeover buzz is driving significant volatility and strong call flow, prompting discussions around hedging strategies.

Southport Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on April 13, 2021 and is headquartered in Fairfield, CT.

Angel Studios Inc. - Ordinary Shares - Class A

Angel Studios Inc

Angel Studios ($ANGX) is trending as investors discuss its recent IPO and potential parabolic growth, drawing comparisons to $NFLX in its early stages. Community members are focused on the company's unique "Angel Guild" funding model and its potential for expansion, while also considering the implications of the stock's low float and pending share conversions.

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

ADXN is trending following news of clinical candidate selection from its GABAB collaboration, making it eligible for milestone payments. The community is discussing the potential for a short squeeze due to the low float, but cautioning about potential pump and dump. Some traders are focusing on the company's milestone-driven news and evaluating potential revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates

ADC Therapeutics (ADCT) delivered earnings and revenue surprises of -38.89% and +0.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

TELA Bio (TELA) delivered earnings and revenue surprises of -22.22% and -1.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -900.00% and +13.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Are Medical Stocks Lagging  ADC Therapeutics (ADCT) This Year?

Here is how ADC Therapeutics SA (ADCT) and Alnylam Pharmaceuticals (ALNY) have performed compared to their sector so far this year.

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland, Feb. 3, 2025 LAUSANNE...

ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference

ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference PR Newswire LAUSANNE, Switzerland, Jan. 30...

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan ADC Therapeutics Makes Grants to New Employees Under Inducement Plan PR Newswire LAUSANNE, Switzerland, Jan. 2, 2025 LAUSANNE...

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma

ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma ADC Therapeutics Announces...

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell...

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Adc Therapeutics SA

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with $OPEN stock after the major announcements last night?

Stocktwits

Opendoor Technologies Inc

 stock after the major announcements last night?

Current Price	$3.33
Prev Close	$3.23
Open	$3.27
Dividend Yield	0.00%
50-Day Moving Average	$3.06
Beta	1.41
Avg. Volume	692,649.10
PE Ratio	-2.06

52-Week High	$3.97
52-Week Low	$1.05
Market Capitalization	$363.37M
EPS (Annual)	-$1.62
Price to Book	-1.82
Revenue Per Employee	$267,309.43
Enterprise Value/EBITDA	N/A

ADCT
Adc Therapeutics SA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADCT News

ADCT Adc Therapeutics SA